Bacterin International Holdings Inc (BONE) Is a New Pick For This Hedgie: The Details

Page 2 of 2

In Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) the hedge fund disclosed a $76.2 million stake, which involves about 1.9 million shares. In Forest Laboratories, Inc. (NYSE:FRX), the hedge fund holds some 2.0 million shares, worth around $76.2 million. Merck & Co., Inc. (NYSE:MRK) is represented in the Deerfield Management’s equity portfolio by a $54.1 million holding, which contains over 1.2 million shares.

Therefore, Insider Monkey will keep you updated about hedge fund moves around Bacterin International Holdings Inc (NYSEMKT:BONE).

Page 2 of 2